Analgesic Use in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Background: Pain is common in patients with chronic kidney disease (CKD). Analgesics may be appropriate for some CKD patients. Objectives: To determine the prevalence of overall analgesic use and the use of different types of analgesics including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), adjuvants, and opioids in patients with CKD. Design: Systematic review and meta-analysis. Setting: Interventional and observational studies presenting data from 2000 or later. Exclusion criteria included acute kidney injury or studies that limited the study population to a specific cause, symptom, and/or comorbidity. Patients: Adults with stage 3-5 CKD including dialysis patients and those managed conservatively without dialysis. Measurements: Data extracted included title, first author, design, country, year of data collection, publication year, mean age, stage of CKD, prevalence of analgesic use, and the types of analgesics prescribed. Methods: Databases searched included MEDLINE, CINAHL, EMBASE, and Cochrane Library. Two reviewers independently screened all titles and abstracts, assessed potentially relevant articles, and extracted data. We estimated pooled prevalence of analgesic use and the I 2 statistic was computed to measure heterogeneity. Random-effects models were used to account for variations in study design and sample populations, and a double arcsine transformation of the prevalence variables was used to accommodate potential overweighting of studies with very large or very small prevalence measurements. Sensitivity analyses were performed to determine the magnitude of publication bias and assess possible sources of heterogeneity. Results: Forty studies were included in the analysis. The prevalence of overall analgesic use in the random-effects model was 50.8%. The prevalence of acetaminophen, NSAIDs, and adjuvant use was 27.5%, 17.2%, and 23.4%, respectively, while the prevalence of opioid use was 23.8%. Due to the possibility of publication bias, the actual prevalence of acetaminophen use in patients with advanced CKD may be substantially lower than this meta-analysis indicates. A trim-and-fill analysis decreased the pooled prevalence estimate of acetaminophen use to 5.4%. The prevalence rate for opioid use was highly influenced by 2 large US studies. When these were removed, the estimated prevalence decreased to 17.3%. Limitations: There was a lack of detailed information regarding the analgesic regimen (such as specific analgesics used within each class and inconsistent accounting for patients on multiple drugs and the use of over-the-counter analgesics such as acetaminophen and NSAIDs), patient characteristics, type of pain being treated, and the outcomes of treatment. Data on adjuvant use were very limited. These results, therefore, must be interpreted with caution. Conclusions: There was tremendous variability in the prescribing patterns of both nonopioid and opioid analgesics within and between countries suggesting widespread uncertainty about the optimal pharmacological approach to treating pain. Further research that incorporates robust reporting of analgesic regimens and links prescribing patterns to clinical outcomes is needed to guide optimal clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, paracetamol remains the mainstay analgesic option in patients with chronic kidney disease.92”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Comparison of two methods to detect publication bias in meta-analysis.
Peters, J. L. (2006) · JAMA · doi:10.1001/jama.295.6.676 · Cited by 2,278
Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2013-203104 · Cited by 2,169
Davison, S. N., Levin, A., Moss, A. H., Jha, V., Brown, E. A., Brennan, F., Murtagh, F. E. M., Naicker, S., Germain, M. J., O'Donoghue, D. J., et al. (2015) · Kidney International · doi:10.1038/ki.2015.110 · Cited by 580
Self-citationJadoul, M., Albert, J. M., Akiba, T., Akizawa, T., Arab, L., Bragg-Gresham, J. L., Mason, N., Prutz, K.-G., Young, E. W., & Pisoni, R. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001754 · Cited by 466
Pain in hemodialysis patients: prevalence, cause, severity, and management
Davison, S. N. (2003) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.025 · Cited by 403
Self-citationElder, S. J., Pisoni, R. L., Akizawa, T., Fissell, R., Andreucci, V. E., Fukuhara, S., Kurokawa, K., Rayner, H. C., Furniss, A. L., Port, F. K., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm630 · Cited by 320
Impact of Pain and Symptom Burden on the Health-Related Quality of Life of Hemodialysis Patients
Davison, S. N., & Jhangri, G. S. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.08.008 · Cited by 297
Self-citationFalls in hemodialysis patients: Prospective study of incidence, risk factors, and complications
Desmet, C., Beguin, C., Swine, C., & Jadoul, M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.027 · Cited by 182
Research works printed but not linked: 6
- National Pain Centre. The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain (J Busse, ed.), 2018, http://nationalpaincentre.mcmaster.ca/documents/Opioid%20GL%20for%20CMAJ_01may2017.pdf. Accessed February 24, 2020.
- Schwarzer G, R News, 2007, 40
- Gamondi C, 2013, Swiss Med Wkly, 143, w13750
- Iacono SA., 2004, Dialysis Transplant, 33, 92
- Yesil S, 2015, Agri, 27, 197
- Brkovic T, 2016, Patient Prefer Adherence, 10, 1131
Cited by
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“Thus, paracetamol remains the mainstay analgesic option in patients with chronic kidney disease.(92) It is unnecessary to modify the dose for dialytic patients; however, dose reduction or longer dose interval should be considered in patients with advanced kidney failure.”
BackgroundAlchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
Assessment of glycemia in chronic kidney disease
Hassanein, M., & Shafi, T. (2022) · BMC Medicine · doi:10.1186/s12916-022-02316-1 · Cited by 48
“Pain is common in patients with neuropathy and osteoarthritis and is preferentially treated with acetaminophen in patients with CKD [63].”
BackgroundDrug stewardship in chronic kidney disease to achieve effective and safe medication use
Hall, R. K., Kazancıoğlu, R., Thanachayanont, T., Wong, G., Sabanayagam, D., Battistella, M., Ahmed, S. B., Inker, L. A., Barreto, E. F., Fu, E. L., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00823-3 · Cited by 43
“18–20% of people with grade 3–5 CKD receive at least one potentially inappropriate nephrotoxic medication annually, primarily non-NSAIDs, antiviral agents, fenofibrates, bisphosphonates and proton pump inhibitors (PPIs) 62,90,91 .”
Lambourg, E. J., Colvin, L., Guthrie, G. D., Walker, H., & Bell, S. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.08.035 · Cited by 31
Metadata
- Authors
- Davison, S. N., Rathwell, S., George, C., Hussain, S. T., Grundy, K., & Dennett, L.
- Affiliations
- University of Alberta (CA)
- Christchurch Hospital (NZ)
- Corresponding author
- Davison, Sara N.
- Venue
- Canadian Journal of Kidney Health and Disease
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 7
- Pages
- 2054358120910329-2054358120910329
- ISSN
- 2054-3581 (ISSN-L)
- PMC
- PMC8851133
- OpenAlex
- W3009598601
- Cited by
- 25
- References
- 55
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Canadian Journal of Kidney Health and Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- analgesic use, chronic kidney disease, advanced CKD, pain management, paracetamol, nonsteroidal anti-inflammatory drugs, adjuvant analgesics, opioid use, dialysis patients, conservative treatment, publication bias, over-the-counter analgesics, drug safety in kidney disease, end-of-life care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analgesic Use in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1177/2054358120910329
- The paper
- Davison, S. N., Rathwell, S., George, C., Hussain, S. T., Grundy, K., & Dennett, L. (2020). Analgesic Use in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Canadian Journal of Kidney Health and Disease. https://doi.org/10.1177/2054358120910329
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.